Dominant negative ATP5F1A variants disrupt oxidative phosphorylation causing neurological disorders
Sara M. Fielder, Marisa W. Friederich, Daniella Helena Hock, Jessie R. Zhang, Liana Valin, Jill Anne Rosenfeld, Kevin T. A. Booth, Natasha J. Brown, Rocío Rius, Tanavi Sharma, Liana N. Semcesen, Kim C. Worley, Lindsay Catherine Burrage, Kayla M. Treat, Tara E. Samson, , Stephen C. Pak
This study identifies de novo ATP5F1A variants causing neurological disorders through dominant negative mechanisms, expanding the known phenotypic and genotypic spectrum of complex V deficiency.
EMBO Molecular Medicine · Aug 26, 2025Peer-reviewedGenetic & Genomic Medicine